Schroder Investment Management Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Buy |
897,354
+394,791
| +79% | +$679K | ﹤0.01% | 944 |
|
|
2025
Q1 | $1.79M | Buy |
502,563
+259,267
| +107% | +$923K | ﹤0.01% | 922 |
|
|
2024
Q4 | $1.74M | Hold |
243,296
| – | – | ﹤0.01% | 943 |
|
|
2024
Q3 | $2.34M | Sell |
243,296
-525,864
| -68% | -$5.05M | ﹤0.01% | 916 |
|
|
2024
Q2 | $6.17M | Buy |
769,160
+438,377
| +133% | +$3.52M | 0.01% | 735 |
|
|
2024
Q1 | $4.9M | Buy |
330,783
+6,047
| +2% | +$89.6K | 0.01% | 784 |
|
|
2023
Q4 | $2.64M | Buy |
+324,736
| New | +$2.64M | ﹤0.01% | 868 |
|